Ultomiris Drug Market: A Comprehensive Overview
The global Ultomiris (ravulizumab) drug market has experienced remarkable growth, driven by its innovative long-acting formulation and expanding clinical applications. Developed by Alexion Pharmaceuticals and later acquired by AstraZeneca, Ultomiris has emerged as a leading treatment for rare complement-mediated disorders. This article...
English
Arabic
French
Spanish
Deutsch
Turkish
Dutch
Italiano
Russian
Romaian
Portuguese (Brazil)
Greek